RCMI Coordinating Center (RCMI CC) Header Logo

Connection

David Calhoun to Enzyme-Linked Immunosorbent Assay

This is a "connection" page, showing publications David Calhoun has written about Enzyme-Linked Immunosorbent Assay.
  1. Calhoun DA, Juul SE, McBryde EV, Veerman MW, Christensen RD. Stability of filgrastim and epoetin alfa in a system designed for enteral administration in neonates. Ann Pharmacother. 2000 Nov; 34(11):1257-61.
    View in: PubMed
    Score: 0.043
  2. Calhoun DA, Sullivan SE, Lun?e M, Du Y, Christensen RD. Granulocyte-macrophage colony-stimulating factor and interleukin-5 concentrations in premature neonates with eosinophilia. J Perinatol. 2000 Apr-May; 20(3):166-71.
    View in: PubMed
    Score: 0.041
  3. Calhoun DA, Lun?e M, Du Y, Hutson AD, Veerman M, Christensen RD. Granulocyte colony-stimulating factor serum and urine concentrations in neutropenic neonates before and after intravenous administration of recombinant granulocyte colony-stimulating factor. Pediatrics. 2000 Feb; 105(2):392-7.
    View in: PubMed
    Score: 0.041
  4. Calhoun DA, Lunoe M, Du Y, Christensen RD. Granulocyte colony-stimulating factor is present in human milk and its receptor is present in human fetal intestine. Pediatrics. 2000 Jan; 105(1):e7.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support